In 2020, more than 1.7 million Medicare beneficiaries (including almost half of decedents) received hospice services.
In 2020, the number of hospice providers increased by 4.5 percent, due to growth in the number of for-profit hospices, continuing a more than decade-long trend of substantial market entry by for-profit providers.
Between 2019 and 2020, average lifetime length of stay among decedents grew from 92.5 days to 97.0 days, and the median length of stay was stable at 18 days.
Volume of services: In 2020, the number of beneficiaries using hospice services at the end of life continued to grow. However, the share of Medicare decedents using hospice declined between 2019 and 2020, from 51.6 percent to 47.8 percent, as deaths increased more rapidly than hospice enrollments.
Number of Medicare decedents and number of decedents using hospice grew substantially in 2020
Cost growth: Between 2018 and 2020, hospice cost growth was generally modest. Average cost per day for routine home care, the level of care that accounts for more than 98 percent of hospice days, increased 0.5 percent between 2018 and 2019 and 1.2 percent between 2019 and 2020. In contrast, average cost per day for general inpatient care, inpatient respite care, and continuous home care, which are provided relatively infrequently, rose substantially in 2020.
Aggregate Cap: The cap limits the total payments a hospice provider can receive in a year in aggregate. The aggregate cap functions as a mechanism that reduces payments to hospices with long stays and high margins. In 2019, about 19 percent of hospices exceeded the cap; their Medicare aggregate margin was about 22 percent before and 10 percent after application of the cap.
November/December 2023 Issue SUBSCRIBER CONTENT It has become a national priority to understand the needs of high-need, high-cost patients. In this article, we hear the voices of patients and how to prevent ED visits and readmissions.
November/December 2023 Issue SUBSCRIBER CONTENT More hospitals will face readmissions penalties in 2024, per preliminary CMS data. The Centers for Medicare and Medicaid Services will restart its pneumonia readmissions measure.
Bringing together home-based care leadership and healthcare ecosystem partners.
Remington’s Think Tank brings together the nation’s home-based care leadership and healthcare ecosystem partners who have a vested interest in improving care delivery through mutually beneficial partnerships. The Think Tank was founded by executives of the Remington Report and past Think Tank conferences. These executives – who have been at the forefront of healthcare for three decades – have a track record of success with perspectives that span the healthcare ecosystem. As key educators, they focus on navigating, strategizing, and guiding strategic leadership decisions and growth. More than 10,000 C-suite healthcare executives have benefited from The Remington Report and Think Tank insights, education, and strategic planning through multiple platforms, including summits, board retreats, executive leadership programs, peer-to-peer networking groups, and guided consulting.
If you are not receiving our newsletters, then the first thing to do is to check your spam folder. If you can see our newsletters there, then you should whitelist them/report them as not spam. The process for doing so is typically documented by your email product. You can also add us to your contact list (firstname.lastname@example.org).
If you can’t see our newsletters anywhere in your spam folder, then most likely they were filtered out by your organization’s firewall. In this case, you should ask the security team of your IT department to whitelist incoming mail originating from the following IPs:
Start of Range
End of Range
You should also ask them to whitelist the domain: remingtonreport.com
Forgot your password? Just click the "Forgot Password?" link below and enter the subscriber's username or email address. An email will be sent to you with a password reset link. Be sure to check your spam and/or junk mail folders for the email.